English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThis special edition features upcoming presentations by MD Anderson researchers at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, including immunotherapy advances in human papillomavirus (HPV)-positive head and neck cancers, microbiome signatures linked with specialized immune-cell clusters, and promising early activity from novel immunotherapy drugs in advanced melanoma and colorectal cancer.
Tag: HPV and cancer
New treatment option shows promise in clearing HPV infection
Daily use of a mushroom extract supported the immune system in clearing human papillomavirus (HPV) infections, according to researchers with UTHealth Houston. The study was published today in Frontiers in Oncology.
Blood test shows promise for predicting treatment response in metastatic HPV-positive throat cancer
A new blood test could signal whether treatment for metastatic HPV-positive throat cancer is working months earlier than standard imaging scans, allowing doctors to try alternatives sooner, initial results show.
New Patient Guide from NCCN Jumpstarts Important Conversations About Anal Cancer
New and updated patient and caregiver resources from National Comprehensive Cancer Network (NCCN) offer jargon-free, state-of-the-art information on diagnosis, treatment, and surveillance for anal, colon, and rectal cancers.
Perspectives on HIV/AIDS, 40 years after the first cases were officially reported
Saturday, June 5, marks the 40th anniversary of the first official reported cases of what became known as AIDS. The University of Michigan has experts who can discuss. Celeste Watkins-Hayes is a professor of public policy and sociology as well…
Sanford Burnham Prebys and other top U.S. cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track
Sanford Burnham Prebys has joined doctors & scientists across America at National Cancer Institute (NCI)-designated cancer centers & other organizations to issue a joint statement urging the nation’s physicians, parents & young adults to get the human papillomavirus (HPV) vaccination back on track.
HPV Vaccine…the results are in.
It may be hard to believe but it’s been 15 years since the first HPV vaccine was approved in 2006. Now, a new study shows the vaccine has not only resulted in a dramatic decline in human papillomavirus infections, but evidence shows…
Protect Your Cervical Health
Expert from the Gynecologic Oncology Program at Rutgers Cancer Institute of New Jersey shares information about cervical health to highlight cervical health awareness month.